Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK598809 for Smoking Cessation and Relapse Prevention
NCT01188967Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK598809 in nicotine dependence, sponsored by Massachusetts General Hospital. Started Aug 2010; status: completed.
02
Drugs
GSK598809
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01188967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188967.